couter

CANLCannLabs, Inc.

Industrials
Oct 15, 2026 — Potential Dilutive Financing or Strategic Update
Chart by TradingView

The schedule

  • Thu15Oct

    Expected corporate update to address massive working capital deficits and avoid delisting or insolvency.

  • Fri20Nov

    Estimated Q3 2026 earnings announcement, acting as a critical checkpoint for Q4 operational continuity.

  • Fri27Nov
  • Wed10Feb

    Expected policy enforcement clarity from President Trump's administration regarding state-level cannabis testing mandates.

  • Fri26Feb
  • Tue30Mar

    Year-end 2026 financial results detailing annual revenue retention and debt management progress.

  • Fri28May
  • Fri27Aug

Past

  • Fri28Aug

    Estimated announcement for CannLabs' Q2 2026 results, focusing on cash burn and going-concern viability.